Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Wojciechowski

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|February 15, 2024
Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development ParadigmYeamin Huh, Jessica Wojciechowski, Vivek S Purohit
Clinical Pharmacology and Therapeutics|April 17, 2024
Model-Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate-to-Severe Ulcerative ColitisJessica Wojciechowski, Arnab Mukherjee, Christopher Banfield, et al.
The AAPS Journal|June 21, 2014
Dashboard systems: implementing pharmacometrics from bench to bedsideDiane R Mould, Richard N Upton, Jessica Wojciechowski
Clinical Pharmacokinetics|August 1, 2025
Population Modeling of Factor IX Activity Following Administration of Fidanacogene Elaparvovec Gene Therapy in Participants with Hemophilia BJessica Wojciechowski, Puneet Gaitonde, Jim H Hughes, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2024
Exposure-response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostatJim H Hughes, Neeta B Amin, Jessica Wojciechowski, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 1, 2024
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERMYuchen Wang, Luke Fostvedt, Jessica Wojciechowski, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
British Journal of Clinical Pharmacology|March 28, 2022
Population pharmacokinetic-pharmacodynamic modelling of platelet time-courses following administration of abrocitinibJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
Clinical Pharmacokinetics|January 21, 2022
Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic DermatitisJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose SelectionYeamin Huh, Ruolun Qiu, John Prybylski, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|February 15, 2024
Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development ParadigmYeamin Huh, Jessica Wojciechowski, Vivek S Purohit
Clinical Pharmacology and Therapeutics|April 17, 2024
Model-Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate-to-Severe Ulcerative ColitisJessica Wojciechowski, Arnab Mukherjee, Christopher Banfield, et al.
The AAPS Journal|June 21, 2014
Dashboard systems: implementing pharmacometrics from bench to bedsideDiane R Mould, Richard N Upton, Jessica Wojciechowski
Clinical Pharmacokinetics|August 1, 2025
Population Modeling of Factor IX Activity Following Administration of Fidanacogene Elaparvovec Gene Therapy in Participants with Hemophilia BJessica Wojciechowski, Puneet Gaitonde, Jim H Hughes, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2024
Exposure-response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostatJim H Hughes, Neeta B Amin, Jessica Wojciechowski, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 1, 2024
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERMYuchen Wang, Luke Fostvedt, Jessica Wojciechowski, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
British Journal of Clinical Pharmacology|March 28, 2022
Population pharmacokinetic-pharmacodynamic modelling of platelet time-courses following administration of abrocitinibJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
Clinical Pharmacokinetics|January 21, 2022
Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic DermatitisJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose SelectionYeamin Huh, Ruolun Qiu, John Prybylski, et al.
Pageof 3